AstraZeneca is the latest Big Pharma company looking to tap into agentic artificial intelligence (AI), inking a three-year licensing deal…

Charles River is rolling out an artificial intelligence-backed digital pathology platform with a goal of trimming at least one week…

Roche has grabbed a European CE mark for its second Alzheimer’s test that can both confirm the disease and help…

Scientists know that damage to microscopic blood vessels can provide an early warning sign of heart and kidney disease. But…

While GLP-1s like Ozempic and Wegovy are being widely prescribed for weight loss, doctors currently do not have a way…

Roche is set to pay out $750 million upfront to acquire digital pathology specialist Path AI in a move by…

Insulet is upping its guidance after a strong first quarter, though ongoing recalls continue to cast a shadow for investors. …

Johnson & Johnson MedTech is touting positive results from the first clinical study of its Ottava soft-tissue surgical robot, showing…

Olympus has inked a collaboration deal for the global distribution of robot-assisted technologies produced by South Korea’s EndoRobotics with a…

Roche’s Foundation Medicine has linked with Fulgent Genetics to offer a new diagnostic test that identifies a person’s genetic makeup,…